Document Detail


Percutaneous transluminal myocardial revascularisation: current status and future perspectives.
MedLine Citation:
PMID:  11265802     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Percutaneous transluminal myocardial revascularisation presently appears to be a potential palliative treatment for coronary artery disease, neither controlled with drugs nor amenable to available coronary revascularisation techniques. Ongoing trials will provide answer to short and long term efficacy. Recent developments using angiogenic growth factors appear very promising, and the role of growth factors as an adjunct to percutaneous transmyocardial revascularisation with laser remains to be seen.
Authors:
P C Rath; M K Agarwala
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of the Indian Medical Association     Volume:  98     ISSN:  0019-5847     ISO Abbreviation:  J Indian Med Assoc     Publication Date:  2000 Nov 
Date Detail:
Created Date:  2001-03-26     Completed Date:  2001-05-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7505608     Medline TA:  J Indian Med Assoc     Country:  India    
Other Details:
Languages:  eng     Pagination:  715-8     Citation Subset:  IM    
Affiliation:
Apollo Hospital, Hyderabad.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Balloon, Laser-Assisted / methods*
Angioplasty, Transluminal, Percutaneous Coronary / methods*
Coronary Disease / therapy*
Humans
Palliative Care

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Current understanding of pathogenesis of coronary artery disease and its future implications.
Next Document:  Cardiac tumors.